Core Laboratories (CLB) Competitors

$9.04 -0.01 (-0.06%)

Closing price 03:59 PM Eastern

Extended Trading

$9.01 -0.03 (-0.33%)

As of 07:12 PM Eastern

CLB vs. PTEN, HAL, HP, MGY, and NBR

Should you buy Core Laboratories stock or one of its competitors? Core Laboratories's main competitors and comparable companies include Patterson-UTI Energy (PTEN), Halliburton (HAL), Helmerich & Payne (HP), Magnolia Oil & Gas (MGY), and Nabors Industries (NBR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "energy" sector.

How does Core Laboratories compare to Patterson-UTI Energy?

Patterson-UTI Energy (NASDAQ:PTEN) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

97.9% of Patterson-UTI Energy shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 2.2% of Patterson-UTI Energy shares are held by company insiders. Comparatively, 1.3% of Core Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Core Laboratories has a net margin of 3.42% compared to Patterson-UTI Energy's net margin of -0.52%. Core Laboratories' return on equity of 8.94% beat Patterson-UTI Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Patterson-UTI Energy	-0.52%	-0.58%	-0.34%
Core Laboratories	3.42%	8.94%	4.22%

In the previous week, Patterson-UTI Energy had 7 more articles in the media than Core Laboratories. MarketBeat recorded 7 mentions for Patterson-UTI Energy and 0 mentions for Core Laboratories. Patterson-UTI Energy's average media sentiment score of 0.61 beat Core Laboratories' score of 0.00 indicating that Patterson-UTI Energy is being referred to more favorably in the media.

Company	Overall Sentiment
Patterson-UTI Energy	Positive
Core Laboratories	Neutral

Core Laboratories has lower revenue, but higher earnings than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Patterson-UTI Energy	$4.83B	0.82	-$93.64M	-$0.06	N/A
Core Laboratories	$526.52M	0.79	$29.67M	$0.38	23.86

Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 3.8%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Patterson-UTI Energy pays out -666.7% of its earnings in the form of a dividend. Core Laboratories pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Patterson-UTI Energy has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Patterson-UTI Energy presently has a consensus target price of $13.95, suggesting a potential upside of 33.92%. Core Laboratories has a consensus target price of $21.00, suggesting a potential upside of 131.66%. Given Core Laboratories' higher probable upside, analysts clearly believe Core Laboratories is more favorable than Patterson-UTI Energy.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Patterson-UTI Energy	0 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.60
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Patterson-UTI Energy beats Core Laboratories on 10 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Halliburton?

Halliburton (NYSE:HAL) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

In the previous week, Halliburton had 14 more articles in the media than Core Laboratories. MarketBeat recorded 14 mentions for Halliburton and 0 mentions for Core Laboratories. Halliburton's average media sentiment score of 0.81 beat Core Laboratories' score of 0.00 indicating that Halliburton is being referred to more favorably in the media.

Company	Overall Sentiment
Halliburton	Positive
Core Laboratories	Neutral

Halliburton has a net margin of 8.90% compared to Core Laboratories' net margin of 3.42%. Halliburton's return on equity of 18.36% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Halliburton	8.90%	18.36%	7.84%
Core Laboratories	3.42%	8.94%	4.22%

Halliburton has higher revenue and earnings than Core Laboratories. Halliburton is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Halliburton	$22.18B	1.23	$1.28B	$2.39	13.78
Core Laboratories	$526.52M	0.79	$29.67M	$0.38	23.86

Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 2.1%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Halliburton pays out 28.5% of its earnings in the form of a dividend. Core Laboratories pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Halliburton has increased its dividend for 4 consecutive years. Halliburton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

85.2% of Halliburton shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 0.6% of Halliburton shares are held by company insiders. Comparatively, 1.3% of Core Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Halliburton currently has a consensus price target of $43.86, indicating a potential upside of 33.16%. Core Laboratories has a consensus price target of $21.00, indicating a potential upside of 131.66%. Given Core Laboratories' higher possible upside, analysts plainly believe Core Laboratories is more favorable than Halliburton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Halliburton	1 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.71
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Halliburton has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Summary

Halliburton beats Core Laboratories on 13 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Helmerich & Payne?

Core Laboratories (NYSE:CLB) and Helmerich & Payne (NYSE:HP) are both energy companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

In the previous week, Helmerich & Payne had 5 more articles in the media than Core Laboratories. MarketBeat recorded 5 mentions for Helmerich & Payne and 0 mentions for Core Laboratories. Helmerich & Payne's average media sentiment score of 0.08 beat Core Laboratories' score of 0.00 indicating that Helmerich & Payne is being referred to more favorably in the news media.

Company	Overall Sentiment
Core Laboratories	Neutral
Helmerich & Payne	Neutral

Core Laboratories has a net margin of 3.42% compared to Helmerich & Payne's net margin of -3.43%. Core Laboratories' return on equity of 8.94% beat Helmerich & Payne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	3.42%	8.94%	4.22%
Helmerich & Payne	-3.43%	-2.35%	-0.99%

Core Laboratories has higher earnings, but lower revenue than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$526.52M	0.79	$29.67M	$0.38	23.86
Helmerich & Payne	$3.75B	0.98	-$163.70M	-$1.41	N/A

Core Laboratories currently has a consensus target price of $21.00, suggesting a potential upside of 131.66%. Helmerich & Payne has a consensus target price of $44.36, suggesting a potential upside of 21.15%. Given Core Laboratories' stronger consensus rating and higher probable upside, equities research analysts clearly believe Core Laboratories is more favorable than Helmerich & Payne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Helmerich & Payne	2 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 96.1% of Helmerich & Payne shares are held by institutional investors. 1.3% of Core Laboratories shares are held by insiders. Comparatively, 4.4% of Helmerich & Payne shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Core Laboratories has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Helmerich & Payne has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 2.7%. Core Laboratories pays out 10.5% of its earnings in the form of a dividend. Helmerich & Payne pays out -70.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Core Laboratories beats Helmerich & Payne on 10 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Magnolia Oil & Gas?

Magnolia Oil & Gas (NYSE:MGY) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, Magnolia Oil & Gas had 20 more articles in the media than Core Laboratories. MarketBeat recorded 20 mentions for Magnolia Oil & Gas and 0 mentions for Core Laboratories. Magnolia Oil & Gas' average media sentiment score of 0.42 beat Core Laboratories' score of 0.00 indicating that Magnolia Oil & Gas is being referred to more favorably in the media.

Company	Overall Sentiment
Magnolia Oil & Gas	Neutral
Core Laboratories	Neutral

94.7% of Magnolia Oil & Gas shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 0.9% of Magnolia Oil & Gas shares are owned by company insiders. Comparatively, 1.3% of Core Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Magnolia Oil & Gas currently has a consensus price target of $31.39, suggesting a potential upside of 32.06%. Core Laboratories has a consensus price target of $21.00, suggesting a potential upside of 131.66%. Given Core Laboratories' higher possible upside, analysts plainly believe Core Laboratories is more favorable than Magnolia Oil & Gas.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Magnolia Oil & Gas	0 Sell rating(s)	6 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.75
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Magnolia Oil & Gas has higher revenue and earnings than Core Laboratories. Magnolia Oil & Gas is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Magnolia Oil & Gas	$1.31B	4.29	$325.25M	$2.23	10.66
Core Laboratories	$526.52M	0.79	$29.67M	$0.38	23.86

Magnolia Oil & Gas has a net margin of 25.82% compared to Core Laboratories' net margin of 3.42%. Magnolia Oil & Gas' return on equity of 19.90% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Magnolia Oil & Gas	25.82%	19.90%	12.69%
Core Laboratories	3.42%	8.94%	4.22%

Magnolia Oil & Gas pays an annual dividend of $0.72 per share and has a dividend yield of 3.0%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Magnolia Oil & Gas pays out 32.3% of its earnings in the form of a dividend. Core Laboratories pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Magnolia Oil & Gas has raised its dividend for 3 consecutive years. Magnolia Oil & Gas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Magnolia Oil & Gas has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Summary

Magnolia Oil & Gas beats Core Laboratories on 14 of the 20 factors compared between the two stocks.

How does Core Laboratories compare to Nabors Industries?

Nabors Industries (NYSE:NBR) and Core Laboratories (NYSE:CLB) are both small-cap energy companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Nabors Industries has higher revenue and earnings than Core Laboratories. Nabors Industries is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nabors Industries	$3.27B	0.37	$286.62M	-$4.65	N/A
Core Laboratories	$526.52M	0.79	$29.67M	$0.38	23.86

In the previous week, Nabors Industries had 9 more articles in the media than Core Laboratories. MarketBeat recorded 9 mentions for Nabors Industries and 0 mentions for Core Laboratories. Nabors Industries' average media sentiment score of 0.12 beat Core Laboratories' score of 0.00 indicating that Nabors Industries is being referred to more favorably in the media.

Company	Overall Sentiment
Nabors Industries	Neutral
Core Laboratories	Neutral

Nabors Industries pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Nabors Industries pays out -0.9% of its earnings in the form of a dividend. Core Laboratories pays out 10.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Core Laboratories has a net margin of 3.42% compared to Nabors Industries' net margin of -1.17%. Core Laboratories' return on equity of 8.94% beat Nabors Industries' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nabors Industries	-1.17%	-3.98%	-0.85%
Core Laboratories	3.42%	8.94%	4.22%

Nabors Industries currently has a consensus price target of $103.00, suggesting a potential upside of 28.02%. Core Laboratories has a consensus price target of $21.00, suggesting a potential upside of 131.66%. Given Core Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Core Laboratories is more favorable than Nabors Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nabors Industries	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
Core Laboratories	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

81.9% of Nabors Industries shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 5.3% of Nabors Industries shares are held by insiders. Comparatively, 1.3% of Core Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nabors Industries has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Core Laboratories has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Summary

Core Laboratories beats Nabors Industries on 11 of the 18 factors compared between the two stocks.

Get Core Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLB vs. The Competition

Export

Metric	Core Laboratories	Energy Equipment & Services Industry	Energy Sector	NYSE Exchange
Market Cap	$414.24M	$3.31B	$9.66B	$23.66B
Dividend Yield	0.44%	5.63%	6.19%	3.74%
P/E Ratio	23.78	20.62	21.04	25.31
Price / Sales	0.79	1.59	4.25	3.30
Price / Cash	8.46	18.13	20.32	15.68
Price / Book	1.46	2.29	2.68	3.73
Net Income	$29.67M	$71.65M	$4.34B	$1.08B
7 Day Performance	1.05%	4.01%	1.60%	1.24%
1 Month Performance	-9.33%	-4.58%	-6.10%	-0.05%
1 Year Performance	-41.50%	25.70%	21.29%	5.48%

Core Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLB Core Laboratories	2.9918 of 5 stars	$9.04 -0.1%	$21.00 +132.4%	-44.0%	$414.24M	$526.52M	23.78	3,300	Ex-Dividend
PTEN Patterson-UTI Energy	4.4695 of 5 stars	$11.75 -0.4%	$14.09 +19.9%	+63.1%	$4.48B	$4.83B	N/A	7,900	Positive News Analyst Forecast
HAL Halliburton	4.9569 of 5 stars	$34.08 -1.5%	$43.86 +28.7%	+17.4%	$28.19B	$22.18B	14.26	46,000	Dividend Announcement
HP Helmerich & Payne	4.1787 of 5 stars	$37.94 -2.3%	$44.36 +16.9%	+31.6%	$3.79B	$4.00B	N/A	6,200	News Coverage Positive News Upcoming Earnings Analyst Downgrade
MGY Magnolia Oil & Gas	4.2843 of 5 stars	$24.74 -1.2%	$31.53 +27.4%	+3.7%	$5.86B	$1.31B	10.85	262	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CLB) was last updated on 11/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Summary

How does Core Laboratories compare to Halliburton?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Summary

How does Core Laboratories compare to Nabors Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Do insiders and institutionals hold more shares of PTEN or CLB?

Is PTEN or CLB more profitable?

Does the media favor PTEN or CLB?

Which has higher earnings and valuation, PTEN or CLB?

Is PTEN or CLB a better dividend stock?

Which has more volatility & risk, PTEN or CLB?

Do analysts recommend PTEN or CLB?

Summary

How does Core Laboratories compare to Halliburton?

Does the media prefer HAL or CLB?

Is HAL or CLB more profitable?

Which has preferable earnings and valuation, HAL or CLB?

Is HAL or CLB a better dividend stock?

Do insiders and institutionals have more ownership in HAL or CLB?

Do analysts recommend HAL or CLB?

Which has more risk & volatility, HAL or CLB?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Does the media refer more to CLB or HP?

Is CLB or HP more profitable?

Which has stronger earnings & valuation, CLB or HP?

Do analysts rate CLB or HP?

Do institutionals & insiders hold more shares of CLB or HP?

Which has more risk & volatility, CLB or HP?

Is CLB or HP a better dividend stock?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Does the media refer more to MGY or CLB?

Do institutionals and insiders believe in MGY or CLB?

Do analysts prefer MGY or CLB?

Which has preferable valuation and earnings, MGY or CLB?

Is MGY or CLB more profitable?

Is MGY or CLB a better dividend stock?

Which has more volatility and risk, MGY or CLB?

Summary

How does Core Laboratories compare to Nabors Industries?

Which has better valuation & earnings, NBR or CLB?

Does the media prefer NBR or CLB?

Is NBR or CLB a better dividend stock?

Is NBR or CLB more profitable?

Do analysts prefer NBR or CLB?

Do insiders & institutionals have more ownership in NBR or CLB?

Which has more risk & volatility, NBR or CLB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools